Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

It's a Black-White Thing
2014-06-03

Seasoned American journalist, Donna Bryson, will launch her book at the Bloemfontein Campus. It's a Black-White Thing offers a story of hope for our country thirsty for good news. 
 
During 2008, Bryson – who was also in SA reporting on our first all-race elections – visited the UFS Bloemfontein Campus. The reason: to investigate the raging furore around the now-infamous Reitz event. Speaking to students, staff and two former rectors, she realised that the campus was indeed a microcosmic reflection of our country at large.
 
Now returning to where it all started, Bryson’s book shows that real change is finally taking place. Her stories tell of inspiring individual transformations under the leadership of Prof Jonathan Jansen, Vice-Chancellor and Rector of the UFS.
It's a Black-White Thing offers a story of hope for our country longing for good news.
 
Come join Donna Bryson and Prof Jansen when they will discuss the book during a public event. The launch of her book is hosted by the Institute for Reconciliation and Social Justice, in cooperation with the Department of Communication and Brand Management. The discussion forms part of the university's 20 years of democracy celebration series.
 
It’s a Black-White Thing is Bryson’s first book and was shortlisted for the City Press Tafelberg Nonfiction Award.
 
Date: Thursday 5 June 2014
Time: 10:00 – 11:00
Venue: Flippie Groenewoud Building (FGG), Block B, Room 202, Bloemfontein Campus

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept